We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
| Share Name | Share Symbol | Market | Type |
|---|---|---|---|
| Johnson and Johnson | NYSE:JNJ | NYSE | Common Stock |
| Price Change | % Change | Share Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|
| -0.22 | -0.15% | 149.70 | 149.89 | 147.82 | 149.89 | 6,532,721 | 00:38:06 |
From May 2019 to May 2024
The health-care sector fell amid concerns a new wave of generic drugs could compete with newer biotechnology-based products. Shares of AbbVie and Johnson & Johnson fell after U.S. Food and Drug Administration documents hinted a cheaper competitor for the drug companies' blockbuster anti-inflammatory treatments from a Korean company could be headed to market soon. SciClone Pharmaceuticals rose after the maker of a Hepatitis B treatment said it was reviewing strategic alternatives, having settled a U.S. Securities and Exchange Commission investigation into its China operations.
-By Rob Curran, rob.curran@dowjones.com
(END) Dow Jones Newswires
February 05, 2016 16:26 ET (21:26 GMT)
Copyright (c) 2016 Dow Jones & Company, Inc.
1 Year Johnson and Johnson Chart |
1 Month Johnson and Johnson Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
